Kate Schweitzer
Associate Managing Editor for JAMA Medical News who introduces and closes the episode and provides context for the featured interview.
Top 3 podcasts with Kate Schweitzer
Ranked by the Snipd community
21 snips
Jan 9, 2026 • 5min
Understanding the World Health Organization's GLP-1 Guidelines
Join Kate Schweitzer, Associate Managing Editor at JAMA Medical News, as she unpacks the WHO's new GLP-1 guidelines for obesity treatment. She discusses the urgent need for these recommendations in light of rising obesity rates and the importance of viewing obesity as a chronic disease. Kate emphasizes that GLP-1 medications are not standalone solutions; they should be integrated with comprehensive care and behavioral support. With equity and access at the forefront, she highlights the potential of an oral GLP-1 pill to revolutionize treatment accessibility.
15 snips
Jan 16, 2026 • 5min
FDA Approves the First Oral GLP-1 Drug for Obesity
Kate Schweitzer, the Associate Managing Editor at JAMA Medical News, discusses the groundbreaking FDA approval of the oral semaglutide pill, Wegovy, for obesity treatment. This shift from injections to an oral format may redefine obesity management, offering a more accessible option for many. She explains the significant differences in dosing schedules, absorption challenges, and stringent administration requirements. Additionally, Kate highlights the pill's cost benefits, easier manufacturing, and why clinicians still show a preference for injections. Discover the future of obesity treatment!
12 snips
Mar 13, 2026 • 6min
PrEP Prevents HIV—If Patients Can Get It
Kate Schweitzer, Associate Managing Editor at JAMA Medical News and reporter on public health, talks PrEP access and policy. She outlines PrEP’s evolving options, from injectables to on-demand. She highlights access barriers: stigma, insurance and Medicaid hurdles, and high-cost injectables. She also covers funding cuts, modeling risks to progress, and local innovations like pharmacist prescribing and telehealth.
